Bulk Pharmaceutical API Sources for ziconotide acetate

Bulk Pharmaceutical API Sources for ziconotide acetate

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		16129690
ISpharm		I06-1841
ChemMol		49401954

Bulk Active Pharmaceutical Ingredient (API) Sources for Ziconotide Acetate

Last updated: February 20, 2026

Ziconotide acetate, marketed as Prialt, is a synthetic peptide derived from cone snail venom. Its manufacturing involves complex processes requiring high purity standards. Key API sourcing options include established contract manufacturers, specialized peptide producers, and chemical intermediates suppliers globally.

Primary API Manufacturers and Suppliers

Contract Manufacturing Organizations (CMOs)

Company	Location	Capacity	Notable Capabilities	Notes
Polypeptide Group	UK	High-volume	Peptide synthesis, purification	Supplies clinical and commercial quantities
Bachem	Switzerland, USA	Varied	Peptide manufacturing, GMP facilities	Produces ziconotide under licensing agreements
WuXi AppTec	China	Large-scale	Peptide synthesis, analytical testing	Offers integrated development-to-commercial services
Novasep	France	Medium	Peptide synthesis, purification	Specializes in complex peptides

Peptide Specialty Manufacturers

Company	Location	Focus	Unique Abilities	Notes
GenScript	US	Custom peptide synthesis	High purity, rapid turnaround	Provides scaled batches for clinical trials
Peptide Interactive	UK	Custom peptides	Focus on difficult sequences	Capable of GMP-grade API production

Chemical Intermediate Suppliers

Some suppliers provide the raw materials or intermediates used in peptide synthesis. These include amino acids or peptide building blocks.

Company	Location	Product	Certification	Notes
Merck KGaA	Germany	Amino acids	GMP-compliant	Supplies for peptide synthesis
Cayman Chemical	USA	Peptide reagents	Research-grade	Used in production scaling

Geographic Distribution of API Sources

• Europe: Polypeptide Group, Bachem, Novasep
• North America: WuXi AppTec, GenScript
• Asia: WuXi AppTec, Peptide Interactive, large-scale Chinese peptide producers

Regulatory and Quality Considerations

API suppliers must comply with Good Manufacturing Practice (GMP) standards. Suppliers with approved GMP facilities can supply APIs for commercial use in regulated markets (US FDA, EMA). Procurement involves validation of supplier quality systems, batch release documentation, and traceability.

Sourcing Challenges and Risks

• Complex synthesis: Peptide APIs like ziconotide acetate require advanced synthesis techniques and rigorous purification, which limits the number of capable suppliers.
• Regulatory approval: Some suppliers may not hold GMP certifications, restricting their use for commercial manufacturing.
• Supply chain stability: Dependence on a limited number of providers increases vulnerability, particularly during geopolitical or manufacturing disruptions.

Conclusion

Reliable APIs for ziconotide acetate predominantly come from specialized peptide manufacturers with GMP certification. Established CMOs such as Polypeptide, Bachem, WuXi, and Novasep lead global supply options. Access and continuity depend on supplier validation, regulatory compliance, and manufacturing capacity.

Key Takeaways

• Ziconotide acetate APIs are produced mainly by peptide-focused CMOs with GMP compliance.
• Major sources include Polypeptide Group, Bachem, WuXi AppTec, and Novasep.
• Geographic distribution spans Europe, North America, and Asia, with supply chain risks based on supplier capacity and regulation status.
• Validation involves rigorous quality control, documentation, and regulatory approval procedures.
• Supply chain risks necessitate diversification and supplier qualification.

FAQs

1. What are the main challenges in sourcing ziconotide acetate APIs?
Manufacturing complexity, need for GMP compliance, and limited specialized producers create barriers. Certification and supply capacity are critical.

2. Can smaller biotech companies access GMP-grade ziconotide APIs?
Yes. Larger providers like GenScript and Peptide Interactive offer GMP materials suitable for clinical use; however, capacity for commercial scale must be verified.

3. What are the typical lead times for API procurement?
Lead times vary from 8 to 20 weeks depending on supplier, order size, and regulatory clearance processes.

4. Are there regional restrictions on API sourcing?
Regulatory agencies require GMP certification and batch documentation. Some regions restrict API importation without proper validation.

5. How does supplier qualification impact production?
Qualifying suppliers ensure API quality, regulatory compliance, and supply stability, reducing risks in commercial manufacturing.

---

References

[1] U.S. Food and Drug Administration. (2022). Good Manufacturing Practices for Drugs.
[2] European Medicines Agency. (2022). Guidelines on Good Manufacturing Practice.
[3] Polypeptide Group. (2023). API manufacturing capabilities.
[4] Bachem. (2023). Peptide production services.
[5] WuXi AppTec. (2023). Integrated peptide manufacturing solutions.